Home Cart 0 Sign in  

[ CAS No. 5773-80-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5773-80-8
Chemical Structure| 5773-80-8
Structure of 5773-80-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5773-80-8 ]

Related Doc. of [ 5773-80-8 ]

Alternatived Products of [ 5773-80-8 ]

Product Details of [ 5773-80-8 ]

CAS No. :5773-80-8 MDL No. :MFCD01075720
Formula : C11H7BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :NPMCAVBMOTZUPD-UHFFFAOYSA-N
M.W : 251.08 Pubchem ID :4549852
Synonyms :

Calculated chemistry of [ 5773-80-8 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 58.61
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.01
Log Po/w (XLOGP3) : 3.97
Log Po/w (WLOGP) : 3.3
Log Po/w (MLOGP) : 3.32
Log Po/w (SILICOS-IT) : 3.0
Consensus Log Po/w : 3.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.36
Solubility : 0.011 mg/ml ; 0.0000436 mol/l
Class : Moderately soluble
Log S (Ali) : -4.45
Solubility : 0.00882 mg/ml ; 0.0000351 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.3
Solubility : 0.0125 mg/ml ; 0.0000497 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.07

Safety of [ 5773-80-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5773-80-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5773-80-8 ]
  • Downstream synthetic route of [ 5773-80-8 ]

[ 5773-80-8 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 5773-80-8 ]
  • [ 7499-66-3 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl-formamide at 20℃; for 3 h;
Stage #2: With water In N,N-dimethyl-formamide at 100℃; for 1 h;
Part B. Preparation of 6-bromonaphthalen-2 -amine.; [00748] A solution of the product Part A (5.07g, 20.19mmol) and triethylamine (4.22mL, 3.07g, 30.3mmol) in dry DMF (155mL) was treated with the diphenylphosphoroyl azide (6.55mL, 8.34g, 30.3mmol) followed by stirring at room temperature for 3h. The solution was then treated with water (2OmL) followed by warming at 1000C for Ih. The solution was cooled and the flask fitted with a short- path distillation head and the DMF removed by distillation under high vacuum. The solid residue was dissolved in EtOAc and washed with saturated sodium bicarbonate solution. Filtered through celite and the filtrate was washed with water (3x) and then with brine. Dried over Na2SC^, filtered and concentrated under vacuum to give the title compound as a beige solid (4.48g, 100 percent).
100%
Stage #1: With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl-formamide at 20℃; for 3 h;
Stage #2: With water In N,N-dimethyl-formamide at 100℃; for 1 h;
[00490] Part B. Preparation of 6-bromonaphthalen-2-amine.; [00491] A solution of the product Part A (5.07g, 20.19mmol) and triethylamine (4.22mL, 3.07g, 30.3mmol) in dry DMF (155mL) was treated with the diphenylphosphoroyl azide (6.55mL, 8.34g, 30.3mmol) followed by stirring at room temperature for 3h. The solution was then treated with water (2OmL) followed by warming at 1000C for Ih. The solution was cooled and the flask fitted with a short- path distillation head and the DMF removed by distillation under high vacuum. The solid residue was dissolved in EtOAc and washed with saturated sodium bicarbonate solution. Filtered through celite and the filtrate was washed with water (3x) and then with brine. Dried over Na2SO4, filtered and concentrated under vacuum to give the title compound as a beige solid (4.48g, 100 percent).
100%
Stage #1: With diphenyl phosphoryl azide; triethylamine In N,N-dimethyl-formamide at 20℃; for 3 h;
Stage #2: With water In N,N-dimethyl-formamide at 100℃; for 1 h;
Part 1. Preparation of 6-bromonaphthalen-2 -amine.[00328| A solution of the product Part H (5.07 g, 20.19 mmol) and triethylamine (4.22 mL, 3.07 g,30.3 mmol) in dry N.N-dimethylformamide (155mL) was treated with the diphenylphosphoroyl azide(6.55 mL, 8.34 g, 30.3 mmol) followed by stirring at room temperature for 3 hours. The solution was then treated with water (20 mL) followed by warming at 100 0C for 1 hour. The solution was cooled and the flask fitted with a short-path distillation head and the NN-dimethylformamide was removed by distillation under high vacuum. The solid residue was dissolved in ethyl acetate and washed with saturated sodium bicarbonate solution. The organic layer was filtered through diatomaceous earth, and the filtrate was washed with water (3*) and then with brine. The organic layer was dried overNa2SO4, filtered and concentrated under vacuum to give the title compound as a beige solid (4.48 g,100 percent).
Reference: [1] Patent: WO2009/39127, 2009, A1, . Location in patent: Page/Page column 175
[2] Patent: WO2009/39134, 2009, A1, . Location in patent: Page/Page column 104
[3] Patent: WO2010/111437, 2010, A1, . Location in patent: Page/Page column 74
[4] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 15, p. 3793 - 3799
[5] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 12, p. 1651 - 1655
[6] Patent: US2011/152246, 2011, A1,
[7] Patent: WO2015/65937, 2015, A1, . Location in patent: Paragraph 000705
  • 2
  • [ 5773-80-8 ]
  • [ 50637-83-7 ]
Reference: [1] Patent: WO2011/54834, 2011, A1,
[2] Patent: US2011/306541, 2011, A1,
[3] Patent: US2011/306541, 2011, A1,
[4] Patent: US2011/306541, 2011, A1,
[5] Patent: US2012/219594, 2012, A1,
[6] Patent: WO2011/91446, 2011, A1,
[7] Journal of Medicinal Chemistry, 2014, vol. 57, # 5, p. 2033 - 2046
[8] Patent: CN107286150, 2017, A,
[9] Patent: US2017/253614, 2017, A1,
[10] Patent: WO2010/132601, 2010, A1,
  • 3
  • [ 5773-80-8 ]
  • [ 1590-25-6 ]
Reference: [1] Patent: WO2011/54834, 2011, A1,
[2] Patent: US2012/219594, 2012, A1,
[3] Patent: WO2011/91446, 2011, A1,
[4] Patent: CN107286150, 2017, A,
[5] Patent: US2017/253614, 2017, A1,
  • 4
  • [ 5773-80-8 ]
  • [ 5042-97-7 ]
YieldReaction ConditionsOperation in experiment
93% With copper(l) iodide; copper(l) chloride In N,N-dimethyl-formamide for 4 h; Inert atmosphere; Reflux Example 32
Synthesis of Compound 32 6-chloro-2-naphthoic acid
A suspension of 6-bromo-2-naphthoic acid (3.0 g, 11.47 mmol), CuCl (11.7 g, 114.64 mmol) and CuI (2.19 g, 11.50 mmol) in degassed DMF (45 mL) was heated to reflux under argon in dark for 4 hrs.
After cooling to room temperature, the solution was decanted into H2O (200 mL) and the resulting mixture was extracted with EtOAc (2*500 mL).
The combined organic layers were then washed with H2O (4*500 mL) followed by brine (1*500 mL), dried over MgSO4, filtered and concentrated under reduced pressure to dryness.
The residue was trituated with CH3CN and the solid obtained was then re-crystallized from EtOAc to give the pure product 32 (2.2 g, 93percent) as an off-white solid. HPLC tR 6.47 min.
93% With copper(l) iodide; copper(l) chloride In N,N-dimethyl-formamide for 4 h; Inert atmosphere; Darkness; Reflux Example 66 - Synthesis of Compound 68 6-chloro-2-naphthoic acid686-chloro-2 -naphthoic acidA suspension of 6-bromo-2-naphthoic acid (3.0 g, 11.47 mmol), CuCI (1 1.7 g, 114.64 mmol) and CuI (2.19 g, 1 1.50 mmol) in degassed DMF (45 ml.) was heated to reflux under argon in dark for 4 hrs. After cooling to room temperature, the solution was decanted into H2O (200 ml.) and the resulting mixture was extracted with EtOAc (2 x 500 mL). The combined organic layers were then washed with H2O (4 x 500 mL) followed by brine (1 x 500 mL), dried over MgSO4, filtered and concentrated under reduced pressure to dryness. The residue was trituated with CH3CN and the solid obtained was then re-crystallized from EtOAc to give the pure product 68 (2.2 g, 93percent) as a off-white solid. HPLC fR 6.47 min.
93% With copper(l) iodide; copper(l) chloride In N,N-dimethyl-formamide for 4 h; Reflux; Inert atmosphere; Darkness A suspension of 6-bromo-2-naphthoic acid (3.0 g, 11.47 mmol), CuCI (1 1.7 g, 114.64 mmol) and CuI (2.19 g, 1 1.50 mmol) in degassed DMF (45 ml.) was heated to reflux under argon in dark for 4 hrs. After cooling to room temperature, the solution was decanted into H2O (200 ml.) and the resulting mixture was extracted with EtOAc (2 x 500 ml_). The combined organic layers were then washed with H2O (4 x 500 ml.) followed by brine (1 x 500 ml_), dried over MgSO4, filtered and concentrated under reduced pressure to dryness. The residue was trituated with CH3CN and the solid obtained was then re-crystallized from EtOAc to give the pure product 70 (2.2 g, 93percent) as a off-white solid. HPLC fe 6.47 min
93% With copper(l) iodide; copper(l) chloride In N,N-dimethyl-formamide for 4 h; Inert atmosphere; Darkness; Reflux A suspension of 6-bromo-2-naphthoic acid (3.0 g, 11.47 mmol), CuCl (11.7 g, 114.64 mmol) and CuI (2.19 g, 11.50 mmol) in degassed DMF (45 mL) was heated to reflux under argon in dark for 4 hrs.
After cooling to room temperature, the solution was decanted into H2O (200 mL) and the resulting mixture was extracted with EtOAc (2*500 mL).
The combined organic layers were then washed with H2O (4*500 mL) followed by brine (1*500 mL), dried over MgSO4, filtered and concentrated under reduced pressure to dryness.
The residue was trituated with CH3CN and the solid obtained was then re-crystallized from EtOAc to give the pure product 68 (2.2 g, 93percent) as a off-white solid. HPLC tR 6.47 min.
75% With CuI In N,N-dimethyl-formamide Step 1.
To a solution of 6-bromo-2-naphthoic acid (4.4 g, 17.5 mmol) in 50 mL anhydrous DMF were added CuCl (8.7 g, 87.5 mmol) and CuI (0.2 g).
The slurry was refluxed for 1 hour.
At room temperature it was diluted with 300 mL EtOAc and stirred for 2 hours.
It was filtered through celite.
The filtrate was evaporated in vacuuo to afford 6-chloro-2-naphthoic acid (2.7 g, 75percent). ES-MS: (M+H)+207.

Reference: [1] Patent: US2009/221557, 2009, A1, . Location in patent: Page/Page column 120
[2] Patent: WO2010/96853, 2010, A1, . Location in patent: Page/Page column 104
[3] Patent: WO2010/96854, 2010, A1, . Location in patent: Page/Page column 119
[4] Patent: US2012/141392, 2012, A1, . Location in patent: Page/Page column 57
[5] Patent: US2002/91116, 2002, A1,
[6] Patent: US6632815, 2003, B2,
[7] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 23, p. 6463 - 6466
[8] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 5, p. 1229 - 1234
[9] Patent: WO2017/192304, 2017, A1, . Location in patent: Paragraph 0149
  • 5
  • [ 33626-98-1 ]
  • [ 5773-80-8 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With lithium hydroxide monohydrate In tetrahydrofuran; water
Stage #2: With hydrogenchloride In tetrahydrofuran; water
General procedure: Compound 14 (4.58 g, 20 mmol) in 1:1 THF/H2O (200 mL) was treated with LiOH.H2O (4.2 g, 100 mmol), stirred overnight, and concentrated to a thick slurry and then treated with 2M HCl to pH = 3 and the precipitate was filtered, washed with water and dried under vacuum to provide 3.8 g (88percent) of 15 as a white powder
84% With potassium hydroxide In methanol at 50℃; for 8 h; A suspension of methyl 6-bromo-2-naphthoate (3b) (2.7 g, 10.0 mmol) and potassium hydroxide (1.1 g, 20.0 mmol) in methanol (50 mL) was vigorously stirred at 50 °C. The reaction mixture becomes homogeneous after the consumption of the initial compound 3b. After 8 h, the solvent was evaporated under reduced pressure (ca 2/3 vol.), water (1500 mL) was added and the unreacted ester extracted with ethyl acetate. The aqueous solution was acidified with 10percent H2SO4 to pH 3 and, after extraction with ethyl acetate (3 .x. 200 mL) and drying on anhydrous sodium sulfate, removal of the solvent afforded the pure acid 3a (2.1 g, 8.4 mmol, 84percent yield). Mp 290-294 °C (decomp.); HRMS (ESI+): m/z [M+1]+ Calcd for C11H8BrO2: 252.08591. Found: 252.08582. 1H NMR (DMSO-d6) δ = 7.72 (1 H, dd, J = 8.5 and 1.8 Hz, 7-naphthyl H), 7.99 (1 H, d, J = 8.6 Hz, 4-naphthyl H), 8.02 (1 H, dd, J = 8.6 and 1.4 Hz, 8-naphthyl H), 8.09 (1 H, d, J = 8.8 Hz, 3-naphthyl H), 8.30 (1 H, d, J = 1.6 Hz, 5-naphthyl H), 8.62 (1 H, s, 1-naphthyl H), 13.15 (1H, br. s, COOH); 13C NMR (125.76 MHz, DMSO-d6) δ = 121.93, 126.50, 127.61, 128.81, 129.83, 130.01, 130.64, 130.90, 131.63, 136.11, 167.30.
80%
Stage #1: With water; lithium hydroxide In tetrahydrofuran; ethanol at 50℃; for 16 h;
Stage #2: With hydrogenchloride In water
Example 176-BROMONAPHTHALENE-2-CARBOXYLIC ACID [(R)-1-(4-METHANESULFONYLAMINO-3-METHYLPHENYL)ETHYL]AMIDE 17A) 6-BROMONAPHTHALENE-2-CARBOXYLIC ACID To a stirred solution of 6-bromonaphthalene-2-carboxylic acid methyl ester (2 g, 8 mmol) in tetrahydrofuran (66 mL) and ethanol (22 mL) was added a solution of lithium hydroxide (542 mg, 22 mmol) in water (22 mL). The reaction was stirred at 50° C. for 16 hours. After cooling, the organic solvents were removed by evaporation, and the aqueous residue was diluted with water (100 mL) then washed with EtOAc (2.x.50 mL). The aqueous layer was acidified using 1N HCl and the products were extracted with EtOAc (3.x.50 mL). The combined organics were washed with brine (100 mL), dried (MgSO4), filtered and concentrated. Trituration with DCM gave the title compound (1.594 g, 80percent) as an off-white solid.1H NMR (400 MHz, DMSO-d6) δ 7.74 (dd, 1H, J=8.7 Hz, 1.9 Hz), 7.99-8.04 (m, 2H), 8.10 (d, 1H, J=8.8 Hz), 8.32 (s, 1H), 8.64 (s, 1H).
70%
Stage #1: With lithium hydroxide; water In tetrahydrofuran at 20℃; for 48 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 0℃;
Part A. Preparation of 6-bromo-2 -naphthoic acid.; [00746] A solution of methyl 6-bromo-2-naphthoate (7.7Og, 29.0mmol) in 2:1 THF:water (15OmL) was treated with lithium hydroxide hydrate (2.44g, 58.1mmol) followed by stirring at room temperature for 48h. Concentrated under vacuum, diluted with water and cooled to O0C. Acidified to pH3 with 4N HCl. Solids were collected by filtration, dissolved in toluene-EtOAc (ca. 2L) and washed with brine. Dried over Na2SO4, filtered and concentrated under vacuum. Brown solid was triturated with ether, collected by filtration, and dried under vacuum to give the title compound as a nearly white solid (5.07g, 70percent).
70%
Stage #1: With lithium hydroxide; water In tetrahydrofuran at 20℃; for 48 h;
Stage #2: With hydrogenchloride In water at 0℃;
[00487] Example 1. Preparation ofN-(6-(3-tert-butyl-5-(2,4-dioxotetrahydropyrimidin-l(2H)-yl)-2- methoxyphenyl)naphthalen-2-yl)methanesulfonamide (compound IA-LO-2.9).; [00488] Part A. Preparation of 6-bromo-2 -naphthoic acid.; [00489] A solution of methyl 6-bromo-2-naphthoate (7.7Og, 29.0mmol) in 2:1 THF:water (15OmL) was treated with lithium hydroxide hydrate (2.44g, 58.1mmol) followed by stirring at room temperature for 48h. Concentrated under vacuum, diluted with water and cooled to O0C. Acidified to pH3 with 4N HCl. Solids were collected by filtration, dissolved in toluene-EtOAc (ca. 2L) and washed with brine. Dried over Na2SC^, filtered and concentrated under vacuum. Brown solid was triturated with ether, collected by filtration, and dried under vacuum to give the title compound as a nearly white solid (5.07g, 70percent).
70%
Stage #1: With lithium hydroxide monohydrate In tetrahydrofuran; water at 20℃; for 48 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water
Part H. Preparation of 6-bromo-2 -naphthoic acid.[00326] A solution of methyl 6-bromo-2-naphthoate (7.7Og, 29.0mmol) in 2: 1 tetrahydrofuran: water(150 mL) was treated with lithium hydroxide hydrate (2.44 g, 58.1 mmol) followed by stirring at room temperature for 48 hours. The mixture was concentrated under vacuum, diluted with water and cooled to 0 0C. The mixture was acidified to pH3 with 4 N HCl. Solids were collected by filtration, dissolved in toluene-ethyl acetate (ca. 2 L) and washed with brine. The organic layer was dried overNa2SO+, filtered and concentrated under vacuum. The brown solid was triturated with ether, collected by filtration, and dried under vacuum to give the title compound as a nearly white solid (5.07g, 70percent).
56% With potassium hydroxide In methanol at 50℃; for 48 h; Potassium hydroxide (127 mg, 2.26 mmol) was added to a suspension of methyl 6-bromo-2-naphthoate (200 mg, 0.75 mmol) in methanol (50 mL) and the mixture heated at 50 °C for 48 h. The solvent was evaporated and the residue diluted with water (30 mL), acidified with HCl (1 M) and the extracted with ethyl acetate (30 mL * 2). The combined organic layers were dried with anhydrous magnesium sulfate and the solvent evaporated under reduced pressure. The crude product was purified via recrystallization using ethyl acetate to give the product as white crystals (105 mg, yield 56percent). 1H NMR matched that previously reported. 1H NMR (400 MHz, CD3OD): δ 8.58 (s, 1H; Ar-H), 8.14 (s, 1H; Ar-H), 8.06 (dd, J = 1.8, 8.7 Hz, 1H; Ar-H), 7.92 (d, J = 8.7 Hz, 1H; Ar-H), 7.87 (d, J = 8.7 Hz, 1H; Ar-H), 7.64 (dd, J = 1.8, 8.7 Hz, 1H; Ar-H).

Reference: [1] Organic and Biomolecular Chemistry, 2015, vol. 13, # 27, p. 7477 - 7486
[2] Organic and Biomolecular Chemistry, 2015, vol. 13, # 27, p. 7477 - 7486
[3] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 4, p. 1557 - 1568
[4] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
[5] Patent: US2012/88746, 2012, A1, . Location in patent: Page/Page column 47-48
[6] Patent: WO2009/39127, 2009, A1, . Location in patent: Page/Page column 174
[7] Patent: WO2009/39134, 2009, A1, . Location in patent: Page/Page column 103
[8] Patent: WO2010/111437, 2010, A1, . Location in patent: Page/Page column 73-74
[9] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 16, p. 4355 - 4367
  • 6
  • [ 1590-25-6 ]
  • [ 5773-80-8 ]
YieldReaction ConditionsOperation in experiment
70% With sodium hypochlorite; sodium hydroxide In 1,4-dioxane; water at 70℃; for 4 h; 1-(6-bromo-naphthalen-2-yl)ethaneone (0.22 g, 0.88 mmol) obtained in Preparation Example 100 was dissolvedin 3 mL of 1,4-dioxane. NaOH (0.353 g, 8.8 mmol) dissolved in 3 mL of water and 9-11percent NaOCl solution (1.67mL, 2.64 mmol) were added thereto, and the mixture was heated to 70°C and stirred for 4 hours. After addition of NaHSO3aqueous solution and water, the reaction solution was extracted with ether. 1N HCl was added thereto, and the organiclayer was separated, dried with MgSO4 and purified by column chromatography to obtain the title compound (0.156 g,70percent).1H-NMR (CDCl3) δ 8.56 (1H, s), 8.05 (2H, m), 7.79 (2H, m), 7.58 (1H, m).
88% With sodium hydroxide; sodium hypochlorite In 1,4-dioxane; water 6-bromo-2-naphthalenecarboxylic acid (Compound M)
To a solution of sodium hypochlorite (62 ml, 5.25percent in water (w/w), 3.6 g, 48.18 mmol) and sodium hydroxide (6.4 g, 160.6 mmol) in 50 ml of water was added a solution of 2-acetyl-6-bromonaphthalene (Compound L) 4 g, (16.06 mmol) in 50 ml of 1,4-dioxane.
The yellow solution was heated to 70° C. in an oil bath for 2 hours, cooled to ambient temperature, and extracted with ethyl ether (2*50 ml).
The aqueous layers were diluted with NaHSO3 solution (until KI indicator solution remained colorless) and then acidified (pH <2) with 1N sulfuric acid to give a white precipitate.
The mixture was extracted with ethyl ether, and the combined organic phase washed with saturated aqueous NaCl, dried (MgSO4) and concentrated to give 3.54 g (88percent) of the title compound as a solid. 1H NMR (DMSO-d6): δ 8.63 (1H, br s), 8.32 (1H, d, J=2.0 Hz), 8.10 (1H, d, J=8.8 Hz), 8.00-8.05 (2H, m), 7.74 (1H, dd, J=2.0, 8.8 Hz).
88% With sodium hydroxide; sodium hypochlorite In 1,4-dioxane; sulfuric acid; water 6-bromo-2-naphthalenecarboxylic acid (Compound M)
To a solution of sodium hypochlorite (62 ml, 5.25percent in water (w/w), 3.6 g, 48.18 mmol) and sodium hydroxide (6.4 g, 160.6 mmol) in 50 ml of water was added a solution of 2-acetyl-6-bromonaphthalene (Compound L) 4 g, (16.06 mmol) in 50 ml of 1,4-dioxane.
The yellow solution was heated to 70° C. in an oil bath for 2 hours, cooled to ambient temperature, and extracted with ethyl ether (2*50 ml).
The aqueous layers were diluted with NaHSO3 solution (until KI indicator solution remained colorless) and then acidified (pH<2) with IN sulfuric acid to give a white precipitate.
The mixture was extracted with ethyl ether, and the combined organic phase washed with saturated aqueous NaCl, dried (MgSO4) and concentrated to give 3.54 g (88percent) of the title compound as a solid. 1H NMR (DMSO-d6): δ 8.63 (1H, br s), 8.32 (1H, d, J=2.0 Hz), 8.10 (1H, d, J=8.8 Hz), 8.00-8.05 (2H, m), 7.74 (1H, dd, J=2.0, 8.8 Hz).
Reference: [1] Patent: EP3239143, 2017, A2, . Location in patent: Paragraph 0306
[2] Patent: US5877207, 1999, A,
[3] Patent: US5958954, 1999, A,
  • 7
  • [ 580-13-2 ]
  • [ 1590-25-6 ]
  • [ 75-36-5 ]
  • [ 5773-80-8 ]
Reference: [1] Patent: US4454341, 1984, A,
  • 8
  • [ 37796-78-4 ]
  • [ 5773-80-8 ]
YieldReaction ConditionsOperation in experiment
8.29 g at 110℃; for 4.5 h; A glass container of 500 ml, provided with a reflux condenser, a gas injecting tube, an exhaust tube, a temperature measurement tube, and an electromagnetic stirrer, was set up with 210 g (3.5 mol) of acetic acid, 1.66 g (6.66 mmol) of cobalt acetate tetrahydrate, 1.65 g (6.73 mmol) of manganese acetate tetrahydrate, 1.06 g (8.91 mmol) of potassium bromide, 10.0 g (45 2 mmol) of 6-bromo-2-methylnaphthalene, and 5.2 g (51.0 mmol) of acetic acid anhydride. An oxidation reaction for producing BNA was performed by stirring the mixture in the glass container during 4.5 hours under ordinary pressure while keeping the inner temperature of the glass container at 110 degrees C. and injecting pure oxygen with a flow rate of 0.2 litters/minute into the glass container. [0043] After completing the reaction and cooling the reaction liquid to 30 degrees C., the cooled liquid was filtrated to obtain a precipitate as a residue. The obtained residue was dried under reduced pressure of 5 mmHg and 40 degrees C. until being of constant mass. A crude BNA product was thus obtained with a purity of 99.2percent and a weight of 8.29 g.
Reference: [1] Patent: US2013/225860, 2013, A1, . Location in patent: Paragraph 0042; 0043
  • 9
  • [ 1590-25-6 ]
  • [ 5773-80-8 ]
Reference: [1] Patent: US4447452, 1984, A,
  • 10
  • [ 15231-91-1 ]
  • [ 64-19-7 ]
  • [ 5773-80-8 ]
YieldReaction ConditionsOperation in experiment
96% for 1.5 h; Large scale 6-bromo-2-naphthol crystals. Finally, the crude crystals were reintroduced to a mass fraction of 66.7percent with a mass of 2160 Kg Of the acetic acid solution in the re-dissolved, dissolved and then static 1. 5h, filtration, washing, After drying, a recrystallization of 6-bromo-2-naphthoic acid was obtained in a yield of 95. 3percent pure Degrees 99. 55percent, single miscellaneous 0. 45percent
Reference: [1] Patent: CN106542971, 2017, A, . Location in patent: Paragraph 0035
  • 11
  • [ 135-19-3 ]
  • [ 5773-80-8 ]
Reference: [1] Patent: CN106542971, 2017, A,
  • 12
  • [ 580-13-2 ]
  • [ 5773-80-8 ]
Reference: [1] Patent: EP3239143, 2017, A2,
  • 13
  • [ 1590-25-6 ]
  • [ 5773-80-8 ]
  • [ 32405-50-8 ]
Reference: [1] Indian Journal of Chemistry, Section A: Inorganic, Physical, Theoretical & Analytical, 1980, vol. 19, # 7, p. 646 - 649
  • 14
  • [ 67-56-1 ]
  • [ 5773-80-8 ]
  • [ 33626-98-1 ]
YieldReaction ConditionsOperation in experiment
100% Reflux 6-Bromo-2-naphthalenecarboxylic acid (2.4996 g, 10.0 mmol) was added50mL dried egg-shaped flask, add 20mL of anhydrous methanol to dissolve,Then 1 mL of concentrated sulfuric acid was slowly added dropwise and the system was refluxed overnight.TLC tracking until the conversion of raw materials is completed, stop heating,After cooling to room temperature, saturated aqueous sodium carbonate solution was added to quench the reaction.The reaction system was adjusted to neutrality, extracted with ethyl acetate,The organic phase is washed three times with anhydrous sodium sulfate.Concentration under reduced pressure afforded S7 (2.63 g, 100percent yield) as a white solid.
93% Reflux To a solution of 6-bromo-2-naphthoic acid (2.65 g, 10 mmol) in methanol 30 mL,concentrated sulfuric acid 1 mL was added drop wise. The reaction mixture was refluxed for 2 h, then added water 150 mL. The foliated crystal was collected thought filtration. Yield: 93percent;
26.4 g for 7 h; Reflux Reactor to 6-bromo-2-naphthalene carboxylic acid (T-1, manufactured by Tokyo Kasei Kogyo (Ltd.)) (25g, 99.6mmol), concentrated sulfuric acid (5.4ml, 99.6mmol), and methanol (80ml) It was placed. The mixture was stirred with heating under reflux for 7 hours. After cooling to room temperature, water was added to the reaction mixture and extracted with dichloromethane. Aqueous organic layers were washed with sodium carbonate, washed with water, then saturated brine, and dried over anhydrous magnesium sulfate. By concentrating the solution under reduced pressure to give compound (T-2) (26.4g, 99.6mmol) and. Compound (T-2) was used in the next reaction without purification.
Reference: [1] Tetrahedron, 2009, vol. 65, # 7, p. 1349 - 1360
[2] Journal of the American Chemical Society, 2008, vol. 130, # 50, p. 16836 - 16837
[3] Patent: CN107286150, 2017, A, . Location in patent: Paragraph 0153; 0154; 0155; 0156; 0157
[4] European Journal of Medicinal Chemistry, 2015, vol. 102, p. 277 - 287
[5] Patent: JP2016/37458, 2016, A, . Location in patent: Paragraph 0172; 0173
  • 15
  • [ 5773-80-8 ]
  • [ 71590-31-3 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With diphenyl phosphoryl azide; triethylamine In <i>tert</i>-butyl alcohol for 15 h; Reflux
Stage #2: With hydrogenchloride In methanol at -78 - 20℃; for 15 h;
A mixture of 6-bromo-2-naphthoic acid (80.3 g, 319 mmol), diphenylphosphoryL azide (71 mL, 352 mmol) and triethylamine (50 mL, 358 mmol) in fert-butanol (400 mL) was heated to reflux and allowed to stir at this temperature for 15 hours. The reaction mixture was then cooled to room temperature and poured over saturated aqueous NaHC03 solution (6Ψ0 mL) and stirred vigorouslyfor 30 minutes. The resulting suspension was filtered, washed with water (200 mL) and dried in vacuo at 65 °C. The resulting white solid was suspended in MeOH (500 mL) and cooled to -78 °C, then HCl gas was bubbled into the mixture until saturated. The reaction mixture was then allowed to stir at room -temperature for 15 hours, after which time the resulting solids were collected by filtration, then washed with- ice-cold MeOH (100 mL) to provide Compound Int-6a as an off-white solid (74.8 g, 91percent), which was used without further purification. l NM (DMSO-_3/4) 6 10.5-10.0 (br s, 3H), 8.23 (s, 1H), 7.99 (d, J= 9.0 Hz, 1H), 7.92 (d, J= 9.0 Hz, 1H), 7.84 (s, 1H), 7.68-7.65 (m, 1H), 7.56-7.51 (m, 1H . "LRMS: (M+2H)+ = 223.
91%
Stage #1: With diphenyl phosphoryl azide; triethylamine In <i>tert</i>-butyl alcohol for 15 h; Reflux
Stage #2: With sodium hydrogencarbonate In tert-butyl methyl ether for 0.5 h;
Stage #3: With hydrogenchloride In methanol at -78 - 20℃; for 15 h;
Preparation of Compound 1A1AA mixture of 6-bromo-2--naphthoic acid-(80.3 g, 319 mmol),diphenylphosphorylazide (71 mL, 352 mmol) and triethylamine (50 mL, 358 mmol) in fer/-butanol (400 mL) was heated to reflux for 15 hours then cooled to room temperature. The reaction mixture was poured over saturated NaHC03 (600 mL) and stirred vigorously for 30 minutes. The solids were filtered, washed with water (200 mL) and dried under vacuum at 65 °C. The resulting. white solid was suspended in MeOH (500 mL), then HCl(g) was bubbled into the mixture at -78 °C until saturated. The reaction mixture was stirred at room temperature for 15 hours, then the resulting solids were collected by filtration, and washed with ice-cold MeOH (100 mL) to provide Compound 1A as an off- white solid (74.8 g, 91percent). 1H NMR (DMSO-<4) δ 10.5-10.0 (br s, 3H), 8.23 (s, 1H), 7.99 (d, J= 9.0 Hz, 1H), 7.92 (d, J= 9.0 Hz, 1H), 7.84 (s, 1H), 7.68-7.65 (m, 1H), 7.56-7.51 (m, 1H). LRMS: (M+2H)+ = 223.
Reference: [1] Patent: WO2011/87740, 2011, A1, . Location in patent: Page/Page column 74
[2] Patent: WO2011/66241, 2011, A1, . Location in patent: Page/Page column 108
[3] Patent: EP2545060, 2015, B1, . Location in patent: Paragraph 0328; 0329
  • 16
  • [ 5773-80-8 ]
  • [ 100751-63-1 ]
YieldReaction ConditionsOperation in experiment
89% With dimethylsulfide borane complex In tetrahydrofuran at 0 - 20℃; (6-bromo-2-naphthvπmethanol To a solution of 6-bromo-2-naphthoic acid (1g, 3.98mmol) in THF (20ml) at O0C was added 2M borane dimethyl sulfide in THF (0.53 ml, 5.97 mmol) portion wise. The mixture was warmed to RT and stirred overnight. The reaction was cooled to O0C and MeOH was added. The solution was concentrated under reduced pressure. The crude product was purified by column chromatography (EtOAc in heptane) to afford the title compound (0.4 g, 89percent). <n="33"/>LCMS: m/z 238 [M+H]\\
85% With borane-THF In tetrahydrofuran at 0 - 25℃; Into a 250-mL 3-necked round-bottom flask was placed 6-bromo-2-naphthoic acid (10 g, 39.83 mmol, 1.00 equiv), tetrahydrofuran (40 mL). This was followed by the addition of BH3THF (1 M) (80 mL, 2.00 equiv) dropwise with stirring at 0°C. The resulting solution was stirred overnight at 25°C. The reaction was then quenched by the addition of 100 mL of ice/water. The resulting solution was extracted with 2x200 mL of ethyl acetate and the organic layers were combined. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. This resulted in 8 g (85percent) of (6-bromonaphthalen-2-yl)methanol as a light yellow solid.
77% With borane-THF In tetrahydrofuran at 0 - 20℃; Preparation of {6- [5- (2-Phenoxy-ethylsulfanylmethyl)- [1, 3,4] oxadiazol-2-yl] -naphthalen- 2-yl}-methanol a) (6-Bromo-naphthalen-2-yl)-methanol A THF solution of 6-bromo-2-naphthoic acid (3.5 g, 13.94 mmol, 1 eq. ) was cooled to 0°C in an ice bath and then treated dropwise with borane-THF complex (1 M solution in THF, 16.7 mL, 16.7 mmol, 1.2 eq. ) via syringe. After addition was complete, the reaction was allowed to gradually warm to room temperature and stir at that temperature overnight. Several milliliters of water were added to the reaction to quench the remainder of the borane. The reaction was diluted with water and extracted with ethyl acetate. The organic layer was separated and then washed with aqueous 1 M NaOH and then brine. The organic layer was then collected, dried over MgSO4, filtered and the solvent removed in vacuo leaving (6-bromo-naphthalen-2-yl) -methanol (2.56 g, 77percent yield) as a white solid in the flask.
74% With diisobutylaluminium hydride In tetrahydrofuran at 0 - 25℃; for 16 h; To a solution of 6-bromo-2-naphthoic acid (1.0 g, 4.0 mmol) in TUF (20 mL) at 0°C was addedDIBAL-H (8.0 mE, 8.0 mmol). After addition, the reaction mixture was stirred at 25 °C for 16h. The rcaction was quenched by the addition of saturated aqueous NH4C1 (20 mE) arid thenextracted with ethyl acetate (3 x 30 mE). The combined organic layers were dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by chromatography(petroleum ether: ethyl acetate 2:1) to give the title compound (0.7 g, 74 percent yield) as a white solid.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 1, p. 267 - 273
[2] Patent: WO2009/130475, 2009, A1, . Location in patent: Page/Page column 31-32
[3] Patent: WO2016/40891, 2016, A2, . Location in patent: Paragraph 00335
[4] Patent: WO2005/40157, 2005, A2, . Location in patent: Page/Page column 83
[5] Patent: WO2016/112284, 2016, A1, . Location in patent: Page/Page column 132; 133
[6] Journal of Medicinal Chemistry, 1993, vol. 36, # 17, p. 2485 - 2493
[7] Patent: JP2016/37458, 2016, A,
[8] Patent: WO2018/118838, 2018, A1, . Location in patent: Paragraph 00249
[9] Patent: CN108530392, 2018, A, . Location in patent: Paragraph 0025; 0033; 0035
  • 17
  • [ 459423-32-6 ]
  • [ 5773-80-8 ]
  • [ 106685-40-9 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With potassium carbonate In tetrahydrofuran; water for 8 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran for 1 h;
Example 3 :Preparation of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2- naphthoic acid (I) :20 ml (12 vol) of tetrahydrofuran, 2 g (7 mmol) of 3-adamantyl-4-methoxyphenylboronic acid (II), 1.65 g (6.6 mmol) of 6 -broτno-2 -naphthoic acid (III) and 20 mL of a 2 M aqueous potassium carbonate solution are introduced into a round-bottomed flask equipped with EPO <DP n="13"/>stirring and under a nitrogen stream. 0.7 g (5percent) of 10percent palladium on carbon (50percent wet; Keraeus type K-0218) is then introduced.The medium is heated under reflux for 8 hours. The catalyst is filtered on a cartridge, and then slowly poured over 30 ml of a 1 N aqueous hydrochloric acid solution.The medium is kept stirring for one hour. The precipitate is filtered, washed with water and then dried under reduced pressure. 2.06 g of 6- [3- (1- adamantyl) -4-methoxyphenyl] -2-naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 79percent; m.p. 321°C) .
99%
Stage #1: With potassium hydroxide In tetrahydrofuran; water at 55℃; for 2 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran at 20℃;
Example 2 :Preparation of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2- naphthoic acid (I) :80 g (0.319 mol) of 6-bromo-2 -naphthoic acid, 95.7 g (0.335 mol, 1.05 eq) of 3 -adamantyl-4 -methoxyphenyl- boronic acid, 0.8 g of 5percent palladium on carbon (50percent wet,Degussa type E105CA/W) and 800 ml of tetrahydrofuran(10 vol) are introduced into a 4 litre reactor. The medium is heated to 55°C. 85 g (1.05 mol, 3.3 eq) of potassium hydroxide at 85percent are dissolved in 240 ml of water (3 vol) .The solution obtained is poured over the reaction medium. The addition is exothermic. The reaction medium reaches the reflux temperature. The reflux is EPO <DP n="12"/>maintained for about 2 hours .The reaction medium is filtered at about 35-400C on a cartridge and rinsed with 400 ml of a THF/water mixture (1/1) .The medium is cooled to 200C and 100 ml of HCl at 35percent in 600 ml of water are added. 6- [3- (1-adamantyl) -4- methoxyphenyl] -2-naphthoic acid precipitates. It is filtered and washed with 4 litres of water. The pH of the washings is about 6-7. The product is dried under vacuum at 1000C for 24 hours.131 g of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2 -naphtho- ic acid are obtained (crude yield = 99percent) .This crude material is dissolved in 15 to 22 volumes of THF under reflux. After filtration in the hot state, 15 to 22 volumes of heptane are added and the medium is cooled to about 50C for 1 to 2 hours.The 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid is filtered on sintered glass and it is rinsed with 1 to 2 volumes of heptane.108 g of 6- [3- (1-adamantyl) -4-methoxyphenyl] -2-naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 82percent; m.p. = 320-3220C) .
94.8%
Stage #1: With potassium carbonate In tetrahydrofuran; water for 2 - 4 h; Heating / reflux
Stage #2: With hydrogenchloride; water In tetrahydrofuran for 1 h;
b) - Preparation of 6- [3- (1-adamantyl) -4-methoxy- phenyl] -2-naphthoic acid (I):20 mL of tetrahydrofuran (12 vol) , 2 g (7 mmol) of 3 -adamantyl-4-methoxyphenylboronic acid (II), 1.65 g (6.6 mmol) of 6-bromo-2 -naphthoic acid (III) and 20 mL of a 2 M aqueous potassium carbonate solution are introduced into a round-bottomed flask equipped with stirring and under a nitrogen stream. 15 mg (1percent) of palladium acetate and 46 mg (2percent) of 2- (dicyclohexyl- phosphino) biphenyl are then introduced. The medium is EPO <DP n="11"/>heated under reflux for 2 hours. Kinetic monitoring by HPLC indicates that the percent of 6- [3- (i-adamantyi) -4- methoxyphenyl] -2 -naphthoic acid formed is 94percent after one hour and 98percent after 2 h.After returning to room temperature, the catalyst is filtered on a cartridge, and then slowly poured over 30 ml of a 1 N aqueous hydrochloric acid solution.The medium is kept stirring for one hour. The precipitate is filtered, washed with water and then dried under reduced pressure. 2.68 g of 6-[3-(l- adamantyl) -4-methoxyphenyl] -2 -naphthoic acid are obtained in the form of a white solid whose purity, determined by HPLC, is 99.9percent (yield = 94.8percent; m.p. = 3210C) .The following melting points (m.p.) exist in the literature: m.p. = 319°-322°C (B. Charpentier et al . , J. Med. Chem., 1995, 38, 4993-5006) and m.p. = 325°-327°C (EP 0 199 636) .
Reference: [1] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 11-12
[2] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 10-11
[3] Patent: WO2006/108717, 2006, A2, . Location in patent: Page/Page column 9-10
  • 18
  • [ 5773-80-8 ]
  • [ 106685-40-9 ]
Reference: [1] Bioorganic Chemistry, 2011, vol. 39, # 4, p. 151 - 158
  • 19
  • [ 5773-80-8 ]
  • [ 74-89-5 ]
  • [ 426219-35-4 ]
YieldReaction ConditionsOperation in experiment
89%
Stage #1: With thionyl chloride; N,N-dimethyl-formamide In toluene at 45 - 50℃; for 1 h;
Stage #2: With triethylamine In methanol; toluene at 10 - 25℃; for 1 h;
Reference Example 76-Bromo-2-naphthoic acid (10.1 g, 40.1 mmol) and N,N- dimethylformamide (4.75 g, 65.0 mmol) were added to toluene (80 mL) . To the reaction mixture was added dropwise thionyl chloride (5.7 g, 48.2 mmol) at 45 to 50°C, and the mixture was stirred for 1 hr, and allowed to cool to room temperature. The reaction mixture was added dropwise at 10 to 25°C to a solution prepared by adding triethylamine (11.4 g, 112.4 mmol) and 40percent methylamine methanol solution (8.1 g, 104.4 mmol) to toluene (80 rnL) , and the mixture was stirred at room temperature for 1 hr.. To the reaction mixture was added dropwise water (50 mL) , and the mixture was stirred at room temperature. The crystals were collected by filtration, and washed with a mixed solvent (25 mL) of methanol/water (2:8) to give wet crystals. The total amount of the wet crystals was added to N,N- dimethylacetamide (70 mL) , and dissolved with heating to 60°C. The reaction mixture was allowed to cool to room temperature, and water (140 mL) was added dropwise thereto. The crystals were collected by filtration, and washed with water (80 mL) to give wet crystals. The total amount of the wet crystals was suspended in ethyl acetate -(25 mL) with stirring at roomtemperature. The crystals were collected by filtration, and washed with ethyl acetate (5 mL) . The obtained wet crystals were dried under reduced pressure to give 6-bromo-N-methyl-2- naphthamide (9.4 g, 35.6 mmol). yield 89percent.3/4 NMR (500 MHz, DMSO-d6) δ 2.84 (d, J = 4.4 Hz, 3H) , 7.71 (dd, J = 8.8, 2.2 Hz, 1H) , 7.93 - 8.03 (m, 3H) , 8.28 (d, J = 1.9 Hz, 1H), 8.44 (s, 1H) , 8.62 (d, J = 4.1 Hz, 1H) ; HRMS (ESI) m/z Calcd for a Ci2HuNOBr [M+H]+: 264.0024, Found: 264.0019; Anal. Calcd for a Ci2Hi0NOBr: C, 54.57; H, 3.82; N, 5.30; Br, 30.25. Found: C, 54.56; H, 3.70; N, 5.34; Br, 30.23.
82% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In tetrahydrofuran; N,N-dimethyl-formamide at 0 - 20℃; for 18 h; Inert atmosphere Under an argon atmosphere, to a cooled (0 °C) solution of 8 (60.26 g, 240 mmol), EDCI*HCl (55.21 g, 288 mmol), HOBt*H2O (44.1 g, 288 mmol) and N,N-diisopropylethylamine ((i-Pr)2NEt) (37.23 g, 288 mmol) in anhydrous N,N-dimethylformamide (DMF) (960 mL) was added dropwise to a solution of MeNH2 (2 M solution in THF; 192 mL, 384 mmol) and the whole was stirred at room temperature for 18 h. After dilution with water, the precipitate was filtered off, washed with H2O and i-Pr2O and dried under the reduced pressure to give 9a (60.6 g, 82percent) as a colorless powder. 1H NMR (CDCl3 + CD3OD) δ: 3.04 (3H, s), 7.60 (1H, dd, J = 1.8 Hz, 8.6 Hz), 7.78 (2H, d, J = 8.6 Hz), 7.85 (1H, dd, J = 1.8 Hz, 8.6 Hz), 8.03 (1H, d, J = 1.8 Hz), 8.25 (1H, s). IR (KBr): 3274, 1638, 1622, 1559, 1495, 1408, 1316, 1159 cm-1. Anal. Calcd for C12H10NOBr.0.1H2O: C, 54.20; H, 3.87; N, 5.27; Br, 30.25. Found: C, 54.03; H, 3.72; N, 5.24.
80%
Stage #1: With thionyl chloride In DMF (N,N-dimethyl-formamide); ethyl acetate at 30 - 65℃; for 0.5 h;
Stage #2: With triethylamine In methanol; DMF (N,N-dimethyl-formamide); water; ethyl acetate at 25℃; for 3 h;
4 Liters of ethyl acetate and 25 ML of DMF were added to 500 g (1.99 mol) of 6-bromo-2-naphthoic acid. 188 ML (2.61 mol, 1.3eq) of thionyl chloride was added dropwise at 30°C or lower..
The mixture was stirred at 65°C for 30 minutes..
After cooled to 25°C, a mixture of 408 ML (3.93 mol, 2eq) of a 40percent solution of methylamine in methanol and 558 ML (4.01 mol, 2eq) of triethylamine was added dropwise at 25°C or lower..
The mixture was stirred at 25°C for 3 hours. 2.5 Liters of water was added dropwise at 25°C or lower..
Crystals were filtered, and washed successively with 1.25 liters of a mixed solution of methanol/water=1/4..
Vacuum drying (50°C) to a constant weight afforded 422 g of 6-bromo-N-methyl-2-naphthamide (yield 80percent).1H NMR (CDCl3+CD3OD): δ 3.04 (3H, s), 7.60 (1H, dd, J=8.6, 1.8 Hz), 7.78 (2H, d, J=8.6 Hz), 7.85 (1H, dd, J=8.6, 1.8 Hz), 8.03 (1H, d, J=1.8 Hz), 8.25 (1H, s).
Reference: [1] Patent: WO2012/173280, 2012, A1, . Location in patent: Page/Page column 32-33
[2] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 21, p. 6356 - 6374
[3] Patent: EP1471056, 2004, A1, . Location in patent: Page 32
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 5773-80-8 ]

Dasabuvir Intermediates

Chemical Structure| 7499-66-3

[ 7499-66-3 ]

6-Bromonaphthalen-2-amine

Chemical Structure| 173194-95-1

[ 173194-95-1 ]

(6-Hydroxynaphthalen-2-yl)boronic acid

Chemical Structure| 33626-98-1

[ 33626-98-1 ]

Methyl 6-bromo-2-naphthoate

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 66-22-8

[ 66-22-8 ]

Pyrimidine-2,4(1H,3H)-dione

Ravidasvir Related Intermediates

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 15761-39-4

[ 15761-39-4 ]

(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid

Chemical Structure| 1575-37-7

[ 1575-37-7 ]

4-Bromobenzene-1,2-diamine

Chemical Structure| 50637-83-7

[ 50637-83-7 ]

2-Bromo-1-(6-bromonaphthalen-2-yl)ethanone

Chemical Structure| 74761-42-5

[ 74761-42-5 ]

MOC-Val-OH

Related Functional Groups of
[ 5773-80-8 ]

Aryls

Chemical Structure| 16650-55-8

[ 16650-55-8 ]

4-Bromo-1-naphthalenecarboxylic acid

Similarity: 0.98

Chemical Structure| 58530-13-5

[ 58530-13-5 ]

3-Bromo-5-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 618-58-6

[ 618-58-6 ]

3,5-Dibromobenzoic acid

Similarity: 0.91

Chemical Structure| 68837-59-2

[ 68837-59-2 ]

4-Bromo-2-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 585-76-2

[ 585-76-2 ]

3-Bromobenzoic acid

Similarity: 0.91

Bromides

Chemical Structure| 16650-55-8

[ 16650-55-8 ]

4-Bromo-1-naphthalenecarboxylic acid

Similarity: 0.98

Chemical Structure| 58530-13-5

[ 58530-13-5 ]

3-Bromo-5-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 618-58-6

[ 618-58-6 ]

3,5-Dibromobenzoic acid

Similarity: 0.91

Chemical Structure| 68837-59-2

[ 68837-59-2 ]

4-Bromo-2-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 585-76-2

[ 585-76-2 ]

3-Bromobenzoic acid

Similarity: 0.91

Carboxylic Acids

Chemical Structure| 16650-55-8

[ 16650-55-8 ]

4-Bromo-1-naphthalenecarboxylic acid

Similarity: 0.98

Chemical Structure| 58530-13-5

[ 58530-13-5 ]

3-Bromo-5-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 618-58-6

[ 618-58-6 ]

3,5-Dibromobenzoic acid

Similarity: 0.91

Chemical Structure| 68837-59-2

[ 68837-59-2 ]

4-Bromo-2-methylbenzoic acid

Similarity: 0.91

Chemical Structure| 585-76-2

[ 585-76-2 ]

3-Bromobenzoic acid

Similarity: 0.91